Clarity Sensors wins $2.4M NIHR award to develop perovskite-based photon-counting CT detectors, potentially making advanced medical imaging cheaper and more accessible.
Cambridge-based semiconductor startup Clarity Sensors just landed a £1.9 million ($2.4 million) award to develop a new generation of photon-counting CT detectors. The goal? Make advanced medical imaging more affordable and accessible for hospitals. And that could mean better, safer scans for patients—especially kids and those who need repeated imaging.
The funding comes as a Product Development Award from the National Institute for Health and Care Research (NIHR) through its Invention for Innovation (i4i) programme. It's a big vote of confidence for a young company that's only been around since 2022.
### Why photon-counting CT matters
Photon-counting CT is a step up from conventional CT. It measures the energy of individual X-ray photons to produce detailed images of tissues and materials. Compared with standard CT, it offers better resolution and significantly lower radiation exposure.
That's a big deal for children and patients who need frequent scans, like those being monitored for cancer or cardiovascular disease. But right now, access is mostly limited to specialist medical centers. Why? The materials used in existing detectors are expensive and complex to manufacture.
Current commercial photon-counting CT detectors rely on cadmium telluride and cadmium zinc telluride crystals. These can take months to grow at temperatures above 1,382°F (750°C). Clarity Sensors is developing an alternative using halide perovskite single crystals that can be grown at around 104°F (40°C) in just a few days.
### A faster, cheaper way to build detectors
Dr. Hayden Salway, CEO of Clarity Sensors, explains: "Photon-counting CT offers real benefits for patients, but the materials it depends on today are slow and costly to make. We grow our perovskite sensors in a matter of days at low temperature, and our initial laboratory results show they can already perform comparably with the materials in current systems."
He adds: "This NIHR award, and our collaboration with STFC's detector specialists, will allow us to turn these results into a complete detector module and test it under the conditions a CT scanner demands. It is a significant step towards our goal of supplying perovskite semiconductor detector technology to CT manufacturers."
The collaboration with STFC's Detector Development Group brings decades of expertise in X-ray imaging. Dr. Matthew Veale from STFC says: "For 20 years, our HEXITEC technology has advanced the field of colour X-ray imaging, bringing capabilities once confined to national science facilities into laboratories and industry. The combination of our next-generation HEXITEC-MHz detector technology with Clarity Sensors' innovative perovskite semiconductor materials represents an exciting opportunity to widen access to affordable colour CT imaging."
### A wave of European funding for medical imaging
Clarity Sensors' award is part of a broader trend. In 2026, several European companies have announced funding for medical imaging and semiconductor-enabled healthcare technologies:
- Bristol-based Siloton secured a £8.7 million ($11 million) Innovate UK contract to develop portable retinal imaging systems.
- Nottingham-based Cerca Magnetics raised £3.7 million ($4.7 million) to scale its quantum-based brain imaging tech.
- London-based MintNeuro secured £3.8 million ($4.8 million) for specialised neural-device semiconductors.
- Belgium's SamanTree Medical received €20 million ($21.6 million) in EIB financing for real-time surgical imaging.
Together, these announcements represent approximately €38.7 million ($41.8 million) in disclosed financing, rising to €40.9 million ($44.2 million) including the full Clarity Sensors project award. The mix includes private investment, public contracts, research awards, and debt financing.
### What's next for Clarity Sensors?
The company's technology addresses one of the key challenges limiting wider adoption of photon-counting CT: the cost and complexity of manufacturing semiconductor materials. If successful, perovskite-based detectors could make advanced imaging more accessible to hospitals everywhere.
For now, the team will use the NIHR award to build a complete detector module and test it under real-world CT scanner conditions. It's a crucial step toward commercialization.
As Dr. Veale puts it: "With NIHR funding, working with Clarity Sensors, we aim to advance knowledge of these emerging materials, improve lives through the development of more accessible medical imaging technologies, and drive growth by strengthening UK sovereign capability in advanced X-ray detector technologies."
In short, this funding could help bring cheaper, safer CT scans to more patients. And that's something we can all root for.